Archive for September, 2009

Simulated Environmental Concepts, Inc.’s (SMEV.PK) Success Built on Their Continued Focus on Customer Service

Wednesday, September 30th, 2009

Since 1997, Simulated Environmental Concepts Inc. and SpaCapsule have been recognized globally as the most innovative and leading provider of massage. Their products are distributed in over 30 countries around the world, including the United States, and are used by both consumers in their homes and also by a variety of businesses.

The SpaCapsule is quickly becoming a common-place occurrence in many environments. SpaCapsule products can be found in a number of settings, being used by a wide variety of businesses including: chiropractic offices, physical therapy centers, medical offices, spas, airports, shopping centers, tanning salons and lounges and rest centers.

The company prides itself on being distinctly different than competitors and has built its success on their continuous commitment to integrity, flexibility and responsiveness in the way they associate with all of their clients. In other words – customer service.

Service is the very foundation of every aspect of the company’s business and they have always dedicated considerable time and resources on ensuring their customers superior service. The company has developed a unique corporate culture where every person at Simulated Environmental Concepts and SpaCapsule is committed to consistently meeting and exceeding customers’ expectations by constantly raising the bar on defining customer service excellence.

The corporate culture at SpaCapsule can best be summed up by their stated policy – “No delivery was ever complete unless our company provided the ultimate in customer satisfaction.”

Let us hear your thoughts: Simulated Environment Concepts Inc. Message Board

ONE Holdings Corp. (ONEZ.OB) Announces Acquisition of Jianou Lujian FoodsStuff

Wednesday, September 30th, 2009

Today, ONE Holdings Corp. announced it has closed on the acquisition of Jianou Lujian FoodsStuff Co. Ltd., effective September 27th, 2009. The announcement occurred under a letter of intent dated August 18, 2009.

ONE’s Vice Chairman and CEO, Marius Silvasan, stated, “Our objective was to close on the acquisition of JLF prior to the end of the third quarter and we did that. JLF is our third acquisition in the last three months. Through these initial key acquisitions we have set up a strong foundation and positioned ourselves with key operating assets which we expect will drive both strong organic and acquisition driven growth. Our focus is clear and is driven by our desire to acquire bioengineering companies located in the Asia Pacific region focused on chemical and herbal extracts, natural supplements and organic products.”

Mr. Silvasan added, “We have acquired in the last 3 months companies generating (based on their 2008 results) more than $50 million dollars in revenue, $11 million in operating income and $8 million in net income. Third quarter financial results will incorporate the results of our recently completed acquisitions and will have our company’s financial picture completely transformed.”

JLF, located in China, is an award-winning green-technology enterprise that specializes in the highly profitable production of organic products and bamboo fertilizers. The company holds land contracts of nearly 6,635 acres in Fujian province, one of China’s largest bamboo growing areas. The company is the third largest bamboo producer in China and is the first to gain food safety certifications from China (HACCP), Japan (JAS) and Europe (EFSA).

Recently, JLF formulated a “zero-to-zero” process starting from cultivation to distribution, including the development of organic fertilizers from bamboo skins to eliminate waste. The innovative process earned JLF the title of 2009’s”Forestry Enterprise of the Year” in Fujian Province China. JLF’s 2008 audited results include revenue, operating income and net income of $16.5 million, $6 million and $4.3 million respectively. During the first two quarters of 2009 JLF generated revenue, operating income and net income of $9 million, $3.2 million and $2.4 million, respectively.

“We are excited to join the ONE Holdings team. ONE adds industry knowledge, operating know-how, and valuable Wall Street connections to facilitate our access to funding required supporting our growth strategy,” commented Mr. Jinrong Tang, Chairman of JLF. “JLF has delivered strong operating results in 2008 and continues to outperform into 2009. Our products are exceptional in quality, competitive in pricing and in growing demand, establishing a strong platform to support our growth efforts,” added Mr. Tang.

Let us hear your thoughts below:

American Sierra Gold Corp. (AMNP.OB) is “One to Watch”

Wednesday, September 30th, 2009

American Sierra Gold Corp. is an independent gold exploration company. Headquartered in Reno, Nevada, their focus is on the strategic exploration and potential development of North American properties. Trading on the OTC Bulletin Board, the Company explores in the Sierra gold belt of northern Mexico. This area has a rich history of large gold and silver discovery.

American Sierra Gold Corp. has a 90 percent interest in 11 concessions in the Sierra Madre Gold Belt. Covering 71,364 acres, they go by the name of the “Urique Project.” This land package represents the largest under-explored acreage in this region. The Urique Project is 10 miles north of the producing El Sauzal Gold Mine, which Gold Corporation owns. Gold Corporation previously purchased this mine from Glamis Gold as part of a transaction worth $8.6 billion in 2006. It has produced 274,200 – 306,900 ounces of gold per year over the past three years.

Last Friday, American Sierra Gold announced that they launched a new, more informative website under the domain name www.americansierragold.com. The new website will keep investors and other interested parties fully informed as the Company continues to move their projects forward.

Mr. Wayne Gruden, President and CEO of American Sierra Gold, brings over 20 years of investing in early stage resource companies. He also worked for nearly 25 years with one of Canada’s largest resource companies, Syncrude Canada. Mr. Ian Foreman is another key technical advisor to American Sierra Gold. Mr. Foreman has worked in a wide spectrum of geological environments involving both base and precious metals. He has worked for various mining and exploration companies in North and South America. He was a key figure in putting the 1,000 tonne-per-day Santa Rosa open pit gold-silver mine into production in Peru.

Today, American Sierra Gold Corp. announced the status of the Urique Project. The Urique’s South Zone consists of an epithermal vein district measuring 2 x 2 km in size with more than 15 historic mines identified to date. Initial sampling has yielded local bonanza grade gold and silver values with highlights of 86.0 g/t (grams per ton) gold and 8,290.0 g/t silver. Located in Urique’s North Zone, the Company’s Cerro Colorado Target is developing ahead of schedule. During its first year of exploration, this section has been advanced to drill-ready stage.

American Sierra Gold’s President and CEO Wayne Gruden sums up progress, saying, “We are excited over the progress being made in our Urique Project. We’ve already seen over 1.3 million dollars of development in the ground. This work is critical to establishing the size of the reserve on the property.”

Let us hear your thoughts below:

Magnum D’Or Resources, Inc. (MDOR) Fat Contracts Prompt Personnel Additions

Wednesday, September 30th, 2009

Magnum D’Or Resources, Inc. is an innovator in rubber reprocessing with the logistical capacity to easily satisfy its 5-year, $131.2 million in open contracts for the production of rubber buffings and nuggets.

However, as Magnum President and CEO Joseph Glusic recently stated, the infrastructural expansion this capital represents demands the immediate retention of several key personnel.

• Dr. Hugh Campbell, Engineering and Science
• Curtis Basner, Operations and Procedure
• Thomas Hillmer, Environmental Compliance
• Paul Miles, Quality Assurance
• Donald Kot, Transportation and Procurement
• Donald Brinkmann, Architectural Design and Construction

Glusic expressed his excitement to be working with this team of “renowned consultants” and noted that each was a specialist in his field of expertise.

Magnum’s has its main 98,000-square-foot facility in Magog (Quebec) and an ancillary 120-acre location in Hudson, Colorado with buildings, equipment, commercially zoned land and a 30,000,000-tire inventory.

Magnum has access, through its proprietary technology and systems, to an emerging global market encompassing everything from industrial raw materials for consumer goods to playground surfacing material. This unprecedented leverage has them poised to revolutionize the massive devulcanization industry in North America and China.

Through its partner Sekhar Research Innovations (SRI), Magnum holds rights and patents to a series of next-generation compounds, techniques and equipment for the production of in-demand, “green” solutions to the waste management of scrap rubber. Having been granted exclusivity for North America, and future Global Rights to the vital compounds and processes necessary to produce the ultra-fine rubber nuggets and powders used to make Elastomeric Alloys (EAs), Magnum is in a lucrative position. These alloys are the first step for end-user products that meet established “green” standards.

Magnum/SRI has a firm grasp on their market sector, and their industrial capacity to produce value-added compounds – which are interchangeable in low tolerance environments without performance degradation – offers customers improved cost efficiency.

Let us hear your thoughts below:

Omnicity Corp. (OMCY.OB) is “One to Watch”

Wednesday, September 30th, 2009

Omnicity Corp. provides broadband access, including advanced services of voice, video and data, in un-served and underserved small and rural markets. The company aims to be the premier consolidator of rural market broadband nationwide. Leveraging management expertise, Omnicity’s strategy is to provide a total broadband solution and continue rapid growth through acquisitions, organic growth and partnerships with Rural Electric Municipal Cooperatives and Rural Telephone Companies.

The company’s target markets are locations better suited to wireless transmissions than traditional hard-wire operators. It has been estimated that at least 40 million rural and small market homes, businesses, government agencies and schools have inadequate high-speed Internet service, representing a large growth opportunity.

Building a nationwide wireless network, Omnicity will be able to deliver high-speed Internet access to rural subscrib¬ers more cost-effectively than traditional cable or fiber optic models since hard-wire systems are gener¬ally much more expensive to build than wireless networks. Reduced network development costs means lower infrastructure costs per subscriber for wireless operators as compared to comparably-sized traditional hardwire fiber-optic systems.

Omnicity is led by an experienced broadband operations team with extensive wireless broadband/ISP expertise as well as the capability to consolidate large numbers of businesses through a strategic roll-up strategy. Over the next five years, the company projects a growing customer base of 170,000 subscribers, increasing margins and growing revenues of nearly $87 million.

Let us hear your thoughts: Omnicity Corp. Message Board

Hana Biosciences, Inc. (HNAB.OB) Attacks Pediatric Cancer

Wednesday, September 30th, 2009

If there is one disease that has plagued our country and people across the globe, it would be cancer. Perhaps there is not a more tragic situation than when a child is stricken down with the deadly disease. One company is trying to make headway into Pediatric Cancer. That company is Hana Biosciences.

The San Francisco based Hana Biosciences is a biopharmaceutical company that has dedicated their resources and time to developing and commercializing new and differentiated cancer therapies with a plan to improve and enable standards of care amongst cancer patients. Hana took a major step towards achieving this goal with the announcement that they have entered into a Clinical Trial Agreement (CTA) with the Center for Cancer Research (CCR) at the National Cancer Institute for the co-development of Marquibo which is a vincristine sulfate liposomes injection in refractory pediatric cancer.

The CTA will occur over five-years which will initially focus on a Phase I trial to evaluate the safety and optimal dose of weekly Marquibo in children and adolescents with refractory cancer. This will be followed by a Phase 2 trial in pediatric acute lymphoblastic leukemia (ALL) which is the most common carrier of childhood cancer. Hana anticipates that the Phase 2 trial will facilitate subsequent studies of Marquibo in combination with standard chemotherapy regimens with the hope that this will lead to improvements in childhood cancer in the future.

Hana Biosciences is led by Steven R. Deitcher M.D. who serves as President and CEO of the company and Anne Hagey M.D. who is the Chief Medical Officer. Deitcher is a renowned name in his field and has published more than 185 journal papers, abstracts and book chapters and has made more than 35 scientific conference presentations. He was the founding editor-in-chief of the journal Current Hematology Reports while Hagey has held a multitude of positions at Abbot Laboratories prior to joining Hana.

When asked about the impact of the Clinical Trial, Dr. Deitcher was quoted as saying, “This agreement expands the clinical development programs for Marqibo and will complement our pivotal Phase 2 rally clinical trial evaluating Marqibo for the treatment of adults with ALL in second relapse. Our combined effort with the NCI will further increase our understanding of Marqibo’s unique activity and ability to supplant standard vincristine in children as well as adults.”

Dr. Hagey added, “Our agreement with the NCI signifies the importance of vinca alkaloids like vincristine in the treatment of pediatric ALL and solid tumors like Wilm’s tumor, rhabdomyosarcoma, and neuroblastoma. The ability to enhance the dosing, tumor penetration, and pharmacokinetic profile of vincristine by the Marqibo formulation has the potential to improve outcomes in children with cancer, a typically underserved area of drug development.”

Currently, Hana Biosciences is trading in the $0.57 range. With this new endeavor and a possibility to make advancements in Pediatric Cancer, Hana may become the over-the-counter gem that all investors dream about.

Let us hear your thoughts below:

Classic Costume Company, Inc. (CCUC.OB) Reports $534K in Orders from Operations of Subsidiary Imperial Coach Works, Inc.

Wednesday, September 30th, 2009

Classic Costume Company, Inc., a business development, marketing and manufacturing conglomerate focused on providing 100 percent electric vehicle and powertrain technologies, recently announced that the company received $534K in signed purchase orders from Imperial Coach Works, Inc. for the months of July and August 2009.

Completion of these purchase orders is estimated to take place within 60 to 90 days from date of execution and will be reported as actual revenues in the fourth quarter report of this year. Working to build a dominating presence in the aftermarket automotive up-fitter segment, including “Pure Electric” vehicles, limousines, other livery, specialty fleet and classic automobiles, the company expects to have the first fully electric, zero emissions livery vehicle ready to unveil by first quarter of next year.

“We are beginning to receive a lot of attention and requests from municipalities wanting to discuss using our ‘Pure Electric’ conversion technologies for their livery and fleet vehicles,” stated Gary Spaniak, chief executive officer of Classic Costume Company, Inc. “Based on the level of interest from these potential customers, I feel confident that we will be a significant provider of ‘Pure Electric’ vehicles by the beginning of 2010.”

Let us hear your thoughts below:

Anavex Life Sciences Corp. (AVXL.OB) Contracts FORENAP for Clinical Trials of Their Alzheimer’s Drug

Wednesday, September 30th, 2009

Swiss-based drug company Anavex Life Sciences Corp. announced today that they have selected FORENAP Pharma as the contract research organization for Phase 1 clinical trials of ANAVEX 2-73, the company’s lead Alzheimer’s drug candidate.

FORENAP has been involved in pre-clinical and clinical research for 20 years and is renowned for its expertise in central nervous system studies, including Alzheimer’s disease. FORENAP will perform study setup, protocol review, site monitoring and project management for the trials. Rudy Luthringer, CEO of FORENAP, said, “We look forward to running a high-quality and cost-effective program as Anavex works to confirm its pre-clinical findings in a clinical setting.”

ANAVEX 2-73 has been shown in pre-clinical testing to be neuroprotective and anti-amnesic. It is thought that the drug impacts mitochondrial dysfunction and it may be mitochondrial protective. Mitochondrial dysfunction is thought by many researchers to be one of the hallmarks of Alzheimer’s disease.

Avanex Life Sciences is approaching Alzheimer’s disease from a different angle. The company’s unique approach with their drug focuses on addressing an underlying cause of Alzheimer’s disease, unlike current drugs on the market that provide only symptomatic relief.

Dr. Herve de Kergrohen, CEO of Anavex Life Sciences, commented on the contract award to FORENAP, “The selection of a world-class contract research organization is an important milestone in our product development process and it underscores our commitment to advance ANAVEX 2-73 through Phase 1 clinical trials. We are moving forward into these trials based on the positive results of our pre-clinical testing, which demonstrated the compound’s significant disease-modifying potential and its powerful anti-amnesic and neuroprotective properties.”

Let us hear your thoughts below:

Data Call Technologies, Inc. (DCLT.OB) Expands Its Network

Wednesday, September 30th, 2009

In a time of general business contraction, Data Call Technologies Inc., key provider of real-time content for digital signage, has once again extended its market. The company recently announced that it is now delivery its digital signage products to Kingston, on the island nation of Jamaica. The move is seen as the latest step in Data Call’s ongoing Caribbean and European initiatives, and just the beginning of a major global outreach.

Jim Ammons, Data Call Technologies Chairman, commented, “We’re truly excited that our products are now being provided in Jamaica. We expect strong continued growth in the Caribbean nations as they seek to deliver real-time, dynamic, and relevant information to island visitors.”

The company also announced that it has now installed products in Hilo, Hawaii, another example of how island retailers, who face unique marketing challenges, are being brought into the digital age. This expands Data Call’s total U.S. distribution coverage to 37 states.

Helping to fuel the expansion is the fact that the cost of digital platforms, displays, and supporting infrastructure are falling dramatically, making digital signage increasingly attractive to a wider range of businesses. Digital signage is now recognized as the premiere method to connect people with relevant information, with the worldwide digital signage industry topping $2 billion, on its way to an estimated $3 billion by 2011.

Data Call plays an important role in the support of digital signage effectiveness by providing real-time content information feeds, helping to draw viewer attention to digital messages. Digital signs, including Data Call feeds, can be seen at airports, sports arenas, banks, clinics, car dealers, manufacturing plants, elevators, and, of course, on billboards. Their feeds can even be sent to cell phones.

Data Call is committed to expanding its product offerings, and plans to move into other vertical markets within targeted industries.

Let us hear your thoughts: DataCall Technologies, Inc. Message Board

Caraco Pharmaceutical Laboratories Inc. (CPD) Gets Back on Track in Generic Drug Market

Wednesday, September 30th, 2009

Companies often stumble in certain areas only to come back stronger and more profitable as issues are addressed and overcome. In certain areas, this particular type of problem is more easily overcome then in others, especially when the profit potential is exceedingly large. The generic drug market is one such area and one that will be extremely profitable in coming years.

Caraco Pharmaceutical Laboratories Inc., a generic drug manufacturer, works to provide generic drugs to a host of mass merchant pharmacy outlets, warehouses, wholesalers and distributors. The company offers a wide array of generic prescription drugs targeted at main stream diseases.

Although the pharma sector has been finding solid successes of late and banked solid capital reserves, there is certain trepidation with regard to product going “off-patent” in the relative near-term. There are many new products to fill this “off-patent” issue, but many products that will leave the patent scenario have been highly profitable. In this regard, companies other than the patent owning companies will be able to benefit.

Caraco Pharmaceutical is one such company. It is also one that is very well diversified in terms of the generic drugs it offers. Conditions that the company offers product to include but are not limited to: analgesics, antibiotics, anticonvulsants, antidepressants, antidiabetics, anti-gouts, antihypertensive/beta blockers, antipsychotics, anti ulcerants, cardiac, decongestants, and narcotic analgesics. The company’s therapeutic drugs also include nonsteroidal antiinflammatory agents, opiate agonist/analgesics, oncology adjuncts, Parkinson’s disease, platelet aggregation inhibitors, sedatives and hypnotics, skeletal muscle relaxants and migraine headache suppressants.

As of 11:30 AM EST, the company is trading up 22.33%. Moving forward the company does appear to be offering product in many high value areas. Looking over past issues, it would appear that Caraco Pharmaceuticals is well positioned to take advantage of off-patent opportunities and will likely find solid profit opportunity in many high value areas.

Let us hear your thoughts below:

Alexza Pharmaceuticals, Inc. (ALXA) To Raise $19 Million in Equity

Wednesday, September 30th, 2009

Alexza Pharmaceuticals, Inc. announced a private placement equity offering of 8.1 million shares of common stock to several qualified institutional investors. The company will receive $2.4325 per share, or approximately $19.1 million in net proceeds.

Alexza Pharmaceuticals also issued 7.3 million warrants as part of the deal. The warrants entitle the holder to purchase 0.9 shares of common stock at $2.77 per share. The warrants expire in seven years.

Alexza Pharmaceuticals is developing a proprietary drug delivery technology called the Staccato® system. This technology vaporizes unformulated pharmaceutical drugs into an aerosol form that allows rapid systemic delivery through lung inhalation.

Alexza Pharmaceuticals has completed Phase 3 trials for using this technology to deliver Loxapine for use in treating schizophrenic or bipolar disorder patients. The company plans a new drug application submission in 2010.

Staccato® is also being tested for use in other areas, including the treatment of migraine headaches, pain and insomnia.

Let us hear your thoughts below:

XFormity Technologies, Inc. (XFMY.OB) Reports Record Financial Results for Year Ending June 2009

Wednesday, September 30th, 2009

XFormity Technologies, Inc., a leading provider of technology services to multi-unit restaurant organizations, today reported its financial results for its fiscal year ending June 30, 2009. The report showed continued revenues and profits growing at a record pace.

The company’s revenues for the year totaled $1,978,231 a 36% increase over the year ending June 2008 with revenues of $1,457,884. “We are very pleased with the direction of the company and with our continued revenue growth” stated Chris Ball XFormity’s CEO. There was also a significant improvement in net profit, with the annual net profit of $786,508 a 162% increase over the year ending 2008 net loss of $1,268,984

“In addition to demand for our core reporting services we are seeing increased interest in our Balanced Scorecard and Financial Benchmarking solutions. Over the past 6 months we have seen increased interest from both franchisees and franchisors across many different brands. We also continue to receive an overwhelming response and very positive feedback on our recently released Cash Management solution. We now have this solution deployed to over 1,200 restaurants,” added Ken Johnson XFormity’s VP of Sales & Marketing.

“As we move forward into the second 1/2 of 2009 we continue to see significant demand for our solutions. Our pipeline continues to stay strong and expect to announce several new large contracts during the next few months. We continue to receive inquiries from numerous food-service organizations that are looking to develop increased visibility into their restaurant operations,” further commented Chris Ball CEO of XFormity.

Let us hear your thoughts below:

Savoy Energy Corp. (SNVP.OB) Finds Profit in its Ability to React in Any Condition

Wednesday, September 30th, 2009

Given the current state of the energy markets, being a large company is not necessarily a good thing. Flexibility is a distinct advantage. Mid and larger energy companies tend to focus on larger properties where capital costs can be extreme, limiting the ability to adapt to changing conditions. As the book says, “small is beautiful.” In a variable market, a company that can adapt quickly is one that will be profitable.

Savoy Energy Corp., an oil and gas extraction company, works to extract and sell oil and gas primarily in the United States. The company recently signed agreements to explore for oil in Fiji.

Although the company is open to all potential properties, it is currently extracting and re-working existing wells in Gonzales, Texas. The company appears to be extremely structured in its operations with a particular focus on cost controls. Generally speaking, the company works with existing technology to bring closed wells back on-line. This process, and the way that the company approaches each well, allows it to keep costs low and cash flow moving in a positive direction. For the most part, the company has been working with smaller tracts of land, ranging in size from 82 acres to 485 acres. It also appears that the company is fairly choosy in the parcels it acquires, purchasing only those tracts it feels it can quickly and easily bring back on-line in short order.

The current state of the oil and gas markets dictates the need for flexibility and the ability to react to quickly changing conditions. In this sense, Savoy Energy is uniquely positioned. As the price of oil and gas move in an uncertain environment, the company is better positioned to react with less exposure if conditions worsen or improve. As companies in all sectors have found out, this is a particular advantage and one that can dictate success or failure. Savoy Energy Corp. has a very prudent and experienced team in place and appears to have found a plan that should keep it moving forward for some time to come regardless of conditions.

Let us hear your thoughts: Savoy Energy Corp. Message Board

The Muscle Flex, Inc. (MFLI.PK) and Sterling Worldwide Entertainment’s Daytime Primetime TV Show Attracts Major Interest from Global Television Distributors

Wednesday, September 30th, 2009

Muscle Flex Inc. and Sterling Worldwide Entertainment, LLC, a subsidiary of Visual Industries, Inc., announced together that their television show “Sugar Free,” which is currently in pre-production, has received significant interest from global television program distributors. According to the press release, they have already engaged the interested media conglomerates in discussions.

Muscle Flex and Sterling each hold a 50% ownership in “Sugar Free” and will equally share future revenues. Currently in the final stages of pre-production, the companies, upon completion, will pitch the show to major television networks and national cable stations for North American and International distribution.

The initial interest is credited to the timely and compelling program content of “Sugar Free” as well as the strong relationships Sterling can leverage in the global television space. Interest in “Sugar Free” is not limited to only program broadcasts, but also extends to sales and distribution of the “Sugar Free” DVD series.

Today, more than 21 million people (7% of the population) have diabetes and even more suffer from obesity and other illnesses. “Sugar Free” delivers real-life, practical solutions to anyone wishing to develop and maintain a healthy lifestyle. Hosted by a top-rated TV celebrity, “Sugar Free” takes a fun, in-your-face approach to demonstrating sugar-free recipes, exercises, and how to maintain a sugar-free life at work events, lunches, and dinners. Celebrity guest appearances will help add variety and depth to keep programming fresh each day.

“Revenue derived from a television program like Sugar Free can be significant. With the huge success of such TV shows as ‘The Biggest Loser’ and ‘Celebrity Fit Club,’ diet and exercise shows have been spun into television gold,” stated Danny Alex, CEO of Muscle Flex Inc. “‘Sugar Free’ has it all — the information, ideas and personalized motivation to help viewers get healthy and stay that way. The show is truly different — it’s a cooking lesson, self-help talk show and reality TV all in one.”

Kira Baskerville, CEO of Sterling Worldwide Entertainment, added, “‘Sugar Free’ will be a show that will help many people worldwide live healthier, longer lives. Sterling is excited to bring ‘Sugar Free’ to the international market place with Muscle Flex.”

“Sterling not only possesses the talent and experience to develop an A-class daytime/primetime TV program but they also have long-standing relationships that can propel ‘Sugar Free’ into widespread distribution globally,” continued Danny Alex, CEO of Muscle Flex Inc. “Sterling has successfully launched health and wellness TV shows globally, including the U.K., Europe and the U.S. ‘Sugar Free’ is one of Muscle Flex’s best kept secrets and its potential has not been fully addressed by investors.”

Further details will later be released in order to protect proprietary content, ideas and information.

Let us hear your thoughts: Muscle Flex Inc. Message Board

General Environmental Management, Inc. (GEVI.OB) Updates Investors on Progress to Enhance Business Strategy

Wednesday, September 30th, 2009

This morning, General Environmental Management, Inc. updated the investment community with the progress made since its Board of Directors elected to shift the company’s business focus from hazardous waste field services to the fast growing water treatment and waste-to-energy markets.

“We are pleased to report that we have made tremendous progress in the execution of our plan to move the company into the water treatment and waste-to-energy markets,” stated Tim Koziol, GEM’s Chief Executive Officer. “As we announced last week, we swiftly moved to sign a binding letter of intent to acquire Santa Clara Waste Water (SCWW). We are conducting final due diligence and plan on closing this transaction on or before November 1, 2009. SCWW will be the cornerstone of our water treatment business. With this profitable business and the addition of GEM’s sales, marketing, operational and regulatory expertise, we believe that we can grow that business significantly in the coming years. In addition, we are actively pursuing two other complementary water treatment businesses that will give GEM even greater capacity to scale revenue.”

Mr. Koziol continued, “We believe that we have one of the best managed and operated field services companies in the country. This business has handled waste streams from some of the biggest companies in the country. We are focused on how to maximize the value of that business while we pave the way for GEM to build its high margin water treatment business and explore opportunities in the waste-to-energy technology market. Our management team has identified two outstanding waste-to-energy technologies that can turn today’s waste products into clean and efficient energy. We will be giving more details on these activities in the coming weeks.”

Mr. Koziol concluded, “Our strategy is very simple. First, maximize the value of our base field services business unit. Next, we will continue to reduce debt and improve the balance sheet. Finally, we will focus our attention on acquiring, licensing or partnering with water treatment and waste-to-energy companies to accelerate high margin revenue. We firmly believe that these strategic moves will best leverage our management team and create sustainable value for our shareholders.”

Let us hear your thoughts: General Environmental Management, Inc. Message Board

Cord Blood America (CBAI.OB) Up 45.45% Following Mention by QualityStocks

Tuesday, September 29th, 2009

Cord Blood America Inc. (OTCBB: CBAI) is up 45.45% today, trading at $0.008. This upward move has occurred on absolutely incredible volume of nearly 1 billion shares! Just a few days ago – on September 25th, QualityStocks highlighted the company in its daily newsletter when the stock was trading for only $0.0031 per share. Cord Blood America is already up 150% in a few short days.

The surge in the company’s stock price followed not only the mention by the QualityStocks newsletter, but also recent news from Cord Blood America – a company which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. The company reported that it is on schedule to complete the construction of its new Las Vegas laboratory by the first week of October. This lab will be perhaps one of the largest cryogenic storage labs in the US.

The subscriber base for the free QualityStocks Daily Newsletter continues to grow by leaps and bounds. From a modest start of only 100 subscribers in January 2006, there are now over 750,000 subscribers to the newsletter. The small cap and micro cap newsletter is like no other – readers are actually viewing data collected from hundreds of other newsletters. To subscribe to the newsletter, visit www.signup.qualitystocks.net.

Let us hear your thoughts below:

The Tradeshow Marketing Company, Ltd. (TSHO.PK) is “One to Watch”

Tuesday, September 29th, 2009

Established in 2003, The TradeShow Marketing Company, Ltd. is a consumer products company. Their focus is on the development and distribution of unique products that have broad appeal and improve the lives of consumers. The Company operates a direct demonstration business via trade shows and exhibitions throughout North America. They also have various product-specific e-commerce web sites.

Earlier this month, Tradeshow Marketing Company, Ltd. announced that they launched their exclusive Risoli™ Titanium Induction cookware set. The Company chose a titanium induction combination for their set because of the advantages it has over most conventional cookware. The set is lightweight and durable because of the Titanium and fused Aluminum construction. In addition, cooking is faster, safer, and more energy efficient when used with an induction cooker.

Yesterday, The Tradeshow Marketing Company, Ltd. announced that they completed an agreement with Seattle-based Cesari Direct. This agreement is for the production of an upcoming short-form Direct Response Television campaign, anticipated to debut on National Television later next month.

“Cesari Direct is a highly reputable company in the DRTV media production field”, said Luniel de Beer, CEO of Tradeshow Marketing. He continued that, “Their experience and success, along with their commitment to excellence, made them our first choice as a partner, and I am very pleased that we were able to complete this agreement with them.”

Let us hear your thoughts below:

Jiangbo Pharmaceuticals Inc. (JGBO.OB) Posts Strong Q4 and FY09 Results, High Expectancies for 2010

Tuesday, September 29th, 2009

Jiangbo Pharmaceuticals Inc. today announced its fiscal and fourth-quarter results for the period ended June 30, 2009. The China-based pharmaceutical company posted solid results for both periods and gave a summary of achievements for the year, as well as its outlook for 2010.

“We are delighted to report a strong finish to fiscal 2009, with revenues and operating income significantly exceeding our prior guidance for the year. We believe that the factors that contributed to this performance were strong sales from our new products and the successful restructuring of our sales and marketing network. With nearly $63 million in operating cash flow in fiscal year 2009, we ended the fiscal year with over $100 million in cash. We believe that our strong cash position will provide us with significant flexibility to pursue continued organic growth and strategic acquisitions,” Wubo Cao, chairman and CEO of Jiangbo stated in the press release.

Revenues grew 10.1 percent to $31.2 million, up from $28.3 million reported the same quarter the year prior. Net income increased 19.9 percent to $11.5, as compared to $9.6 million for the same quarter last year.

For fiscal year 2009 the company posted a 17.9 percent increase to $117.4 million, as compared to $99.5 million for fiscal 2008. Net income grew 28.6 percent to $28.9 million, as compared to $22.5 million for fiscal 2008.

In July 2008, Jiangbo received approval from China’s State Food and Drug Administration (SFDA) for the production and distribution of Radix Isatidis Dispersable Tablets, an herbal-based traditional Chinese medicine for the treatment of viral influenza.

In January 2009, the company acquired Shandong Hongrui Pharmaceutical Company, including all assets and legal rights to distribute Hongrui’s 22 traditional Chinese medicines. The same month, Jiangbo revamped its sales network to accommodate distribution through 28 large regional distributors.

The company anticipates fiscal 2010 to far surpass fiscal 2008 and 2009, expecting revenues for the year between $96 million and $98 million based on the introduction of new drugs and higher volume of various product sales.

“Fiscal 2010 is expected to be a transitional year for Jiangbo as we upgrade our TCM production facility, prepare for the introduction of new drugs, and pursue additional opportunities for both organic growth and potential strategic acquisitions. Our current outlook reflects only the drugs that we have in hand today and will be subject to update as we execute strategic initiatives to expand our market position and profitability in the future. We remain very confident regarding our future growth prospects and look forward to sharing further details with our shareholders as our expansion plans reach a definitive stage,” Cao stated.

Let us hear your thoughts below:

Keryx Biopharmaceuticals, Inc. (KERX) to Raise $20 Million

Tuesday, September 29th, 2009

Keryx Biopharmaceuticals, Inc. is conducting a private placement of stock to qualified institutional investors. The company is issuing 8 million shares of common stock at a price of $2.50, and will realize $20 million in gross proceeds.

Keryx Biopharmaceuticals, Inc. is also issuing warrants to these institutional investors as an incentive to participate in the equity offering. The company will issue warrants to purchase 2.8 million shares of stock. The warrants have an exercise price of $2.65 and expire in approximately one year.

Keryx Biopharmaceuticals, Inc. is currently engaged or planning Phase III clinical trials for two drug candidates, and will use the proceeds to advance those trials.

Perifosine is an oral PI3K/AKT pathway inhibitor for oncology, and is used to treat cancer including multiple myelomas. Zerenex is an iron-based phosphate binder that is used to treat elevated phosphate levels or hyperphosphatemia in patients with end-stage renal disease. Zerenex just finished phase II clinical trials and the company is in talks with the Food and Drug Administration for setting up Phase III.

Let us hear your thoughts below:

US, EU Demand for Oil Declines, Inventories Expected to Rise

Tuesday, September 29th, 2009

With two sets of U.S. weekly oil statistics due out Tuesday and Wednesday expected to confirm fears of high inventories due to low demand, the price of oil dipped to the bottom of its 12-week range. A Reuter’s poll showing a 500,000 barrel inventory increase in the week to September 25 compounded middle distillate forecasts showing a 1.1 million barrel rise.

CEO of Saudi Aramco, Saudi Arabia’s state-run oil company, Khalid Al-Falih indicated Monday that demand from emerging markets and an uptick in China would not offset the loss in demand for oil for some time. Al-Falih also suggested that global consumption would not flag irrevocably and that higher oil prices were needed to fund concurrent development projects.

With the FTSEurofirst 300 broadly falling, U.S. and Brent crude futures were below $65 and $64 respectively by midmorning, Sept. 29. A rebound to $66.59 and $65.71 respectively followed at noon, due to a declining dollar driven by U.S. data showing poor consumer confidence. A Conference Board report detailed the worst job prospects in 26 years, underwriting the slowing demand for oil.

Oil prices have not yet jumped in reaction to rising international tension over OPEC’s second-largest producer, Iran, which recently test-fired a regional-strike-capable missile system on the heels of news about nuclear fuel production in southern Tehran.

Let us hear your thoughts below:

Spire Corp. (SPIR) Signs Contract with South Korean Uni-CHEM Co., Ltd.

Tuesday, September 29th, 2009

Today, Spire Corporation announced that it has entered into two contracts to supply South Korea-based company Uni-CHEM Co., Ltd. with a 60 megawatt (MW) per year turnkey Cell Line and a 50MW per year turnkey Module Line. The contract also includes associated utilities and infrastructure support. The company projects that the Uni-CHEM integrated Cell and Module Lines will become operational in 2010.

Uni-CHEM has agreed to form a US entity, which will purchase 51% of Spire Solar Systems, Spire Corporation’s system integration business. Definitive agreements have not yet to be finalized. Additionally, Uni-CHEM indicated its intent to lease space at the Spire Semiconductor facility in Hudson, New Hampshire to house the automated Cell and Module lines. The companies are currently negotiating the terms of the sublease.

Roger G. Little, Chairman and CEO of Spire Corporation, commented, “We are excited to have finalized the cell and module turnkey manufacturing agreements with Uni-CHEM. We believe their cell and module manufacturing will position them to participate in the US solar market, which is anticipated to be one of the world’s fastest growing. The total value of the contracts, including those relating to the investment in the systems integration business, is approximately $60 million.”

Let us hear your thoughts below:

General Environmental Management, Inc. (GEVI.OB) Offers Clients Waste Minimization Strategies

Tuesday, September 29th, 2009

General Environmental Management Inc. is an environmental and waste management services firm which provides a suite of services for their clients including: field services, remediation, transportation, EHS compliance services, on-site technical services and off-site treatment for both hazardous and non-hazardous materials.

General Environmental assists its clients, which include both public and private institutions, in meeting regulatory requirements for the disposal of wastes. An ongoing, primary focus of the company is to find a reuse or recycle option for clients to reduce the burden of the disposal of waste in our environment.

Another primary focus of the company is waste minimization. What exactly is waste minimization? Waste minimization is any activity that reduces the amount of hazardous material that permanently leaves the production process as waste.

General Environmental considers waste minimization and waste reuse to be the peak of the waste management service pyramid. The company believes reducing waste should be the first consideration in any waste management strategy.

The reasons for institutions to develop a waste minimization plan include:

• Lower costs and greater efficiencies.
• Reduced government scrutiny and intrusion through a reduction in self-reporting obligations.
• Improved community relations through a more positive public image.
• Enhanced employee morale by creating a more inviting and safe work environment.

Waste minimization may include in-plant recycling and improvement of plant operating procedures along with source reduction. Source reduction includes both actions that reduce the net amount of hazardous waste generated and action taken before waste is generated that lessen its hazardous properties. Common source reduction strategies include: materials substitution, product substitution and reformulation, and process or equipment change.

Let us hear your thoughts: General Environmental Management, Inc. Message Board

A123 Systems, Inc. (AONE) is “One to Watch”

Tuesday, September 29th, 2009

Headquartered in Watertown, Massachusetts, A123 Systems, Inc. designs, develops, manufactures, and sells advanced, rechargeable lithium-ion batteries and battery systems. They do this for the transportation, electric grid services, and consumer markets. Founded in 2001, A123 Systems built their proprietary nanoscale electrode technology on initial developments from the Massachusetts Institute of Technology.

A123 Systems, Inc. believes that lithium-ion batteries will play an increasingly important role in facilitating a shift toward cleaner forms of energy. They have developed a broad family of high-power lithium-ion batteries and battery systems using their innovative approach to materials science and battery engineering. Their low impedance Nanophosphate electrode technology provides performance advantages over alternative high power technologies.

Nanophosphate is a positive electrode material of excellent rate capability, critical to high power systems. A123 Systems, Inc.’s high power products are able to pulse at discharge rates up to 100C. They are of a low impedance and thermally conductive design. A123 high power cells can be continuously discharged at a 35C rate.

They designed their cell and electrodes to deliver low cost/watt and cost/watt-hour performance. They have higher voltage than other long-life systems, enabling lower pack cost (when compared to LTO and NiMh). In addition, their long life leads to reduced lifecycle and system costs.

The Company designed their Nanophosphate™ technology to be highly abuse tolerant. They have multiple layers of protection employed at the chemistry, cell, and pack level. This is to achieve an energy storage solution with superior safety and abuse tolerance compared to metal oxide lithium ion. A123 Systems projects their batteries to last up to 10 years. They are suitable for automotive applications including hybrid electric vehicles (HEV) and plug-in hybrid electric vehicles (PHEV).

Let us hear your thoughts below:

Understanding Sector Investing

Tuesday, September 29th, 2009

QualityStocks follows many distinct market segments. Biotech to mining, the QualityStocks team works to address investment opportunity in its many forms. In this regard, the team understands diversification and that individual needs should be addressed by registered investment advisors.

The question begins with need and the certain understanding that diversification is paramount. There are distinct market segments to invest in. The leading segments include: industrials, commodities, technology oriented, biotechnology, fixed income (bonds, treasury securities, municipals), REITS (real estate) and a host of other ideas that financial workers have invented.

As one considers what questions to ask a registered investment advisor, think about risk. Although it may be a generalization, the industrials portion is generally considered to be the income portion of a portfolio. Dividends usually flow from these companies (although less of late given current economic circumstance). Municipals, treasuries and bonds also fall into this particular category of providing reliable income. Remember, however, that there are issues associated in this regard so be sure to ask a registered investment advisor about how costs and values can change.

If an investor wanted to invest on the more risky side they might want to consider commodities. Commodities are basically raw materials. These items might include: corn, sugar, gold, oil or natural gas. The thing to remember in commodities is that one does not necessarily need to invest in the actual product. They can also invest in the company that brings the product to market.

In between these two end-point there are a host of industries among which is technology. This area is a bit more difficult for the average investor to understand but can be profitable if approached correctly. In this segment understand the company and sector before investing. THE MAXUM OF NEVER INVEST IN ANYTHING YOU DO NOT FULLY UNDERSTAND APPLIES HERE.

If an investor were to consider a conservative investment strategy, they might consider a fixed income option. If this is the case, consider a registered investment advisors advice. This is a safe move but one that may find ones capital drained by fees and other economic events. Diversification is the key in this case. Spread investments according to need and conditions and not just fixed income.

QualityStocks follows each area described. Information is the real key. If an investor can follow the sector trends that QualityStocks tends to offer, they may be able to better understand which market sectors might better suit their individual investing needs.

Let us hear your thoughts below:

Axial Vector Energy Corp. (AXVC.PK) Management & Advisory Team

Tuesday, September 29th, 2009

Axial Vector Energy Corp., a leader in energy conversion efficiency, is fortunate in that it is run by one of the most seasoned international management and advisory teams, with over a century of combined experience. This is critical in starting and growing a company, obtaining the required capital, locking in the rights to key products and technologies, and ensuring that your message gets out to the public on a worldwide basis.

• Samuel Higgins, Axial Chairman, has been involved in raising and investing capital globally for over 30 years, with extensive experience in the energy industry, as well as in real estate and technology. His global contacts include his role as Managing Director of a family office in Latin America that advises high net worth individuals. He also has strong connections in the Middle East, and is partner in Emirates International Capital Advisory based in Dubai, where he now lives with his family. He is also known for his lectures on technology development and first-mover breakthrough events affecting GCC (Gulf Cooperation Council) countries.

• Sanjai Chhaunker, Axial President & CEO, is a finance and management professional with expertise in international business, and over 15 years of experience in financial management and business planning. He has provided advisory services to clients in financial and technical collaborations, including technology transfers and marketing. This has helped him develop a strong business network in countries throughout the world, including the U.S., India, UAE, Mexico, Brazil, Canada, Hong Kong, Malaysia, and others.

• Miguel Gonzales, Axial Legal Advisor, is an independent legal consultant and practicing attorney, with over 28 years of legal consulting experience. During this time he was Vice President of Cortez Carbajal y Asociados Law Firm, and is the founder of the law firm Jazo – Gonzalez y Asociados, in charge of the Legal and Corporate Department, and consultant in foreign investment.

• Benjamin Langford, Axial Secretary/Treasurer and Director, is president and CEO of Langford Unlimited, and was earlier the president of Langford Enterprises, involved in technology investments. He started his environment awareness career with Jefferson Smurfit Corporation, a leader in global resources and recycling.

Let us hear your thoughts: Axial Vector Energy Corp. Message Board